Contrast agents are administered for about 30-40% of MRIs. These are typically T1 relaxivity improving agents which use Gadolinium(III). There are six Gd(III) contrast agents FDA approved for clinical use in the United States and ten in Europe.
Copyright © 2026 eLLeNow.com All Rights Reserved.